These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32194154)

  • 41. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
    Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
    Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and impact of anti-HLA-DP antibodies in renal transplantation.
    Hörmann M; Dieplinger G; Rebellato LM; Briley KP; Bolin P; Morgan C; Haisch CE; Everly MJ
    Clin Transplant; 2016 Sep; 30(9):1108-14. PubMed ID: 27327607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor-specific B Cell Memory in Alloimmunized Kidney Transplant Recipients: First Clinical Application of a Novel Method.
    Wehmeier C; Karahan GE; Krop J; de Vaal Y; Langerak-Langerak J; Binet I; Schaub S; Roelen DL; Claas FHJ; Heidt S;
    Transplantation; 2020 May; 104(5):1026-1032. PubMed ID: 31397804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
    Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation.
    Laboux T; Lenain R; Visentin J; Flahaut G; Chamley P; Provôt F; Top I; Kerleau C; Labalette M; Choukroun G; Couzi L; Blancho G; Hazzan M; Maanaoui M
    Transpl Int; 2023; 36():11416. PubMed ID: 38076227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Senev A; Van Loon E; Lerut E; Callemeyn J; Coemans M; Van Sandt V; Kuypers D; Emonds MP; Naesens M
    Kidney Int; 2021 Aug; 100(2):401-414. PubMed ID: 33675843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
    Kwon H; Kim YH; Kim JY; Choi JY; Shin S; Jung JH; Park SK; Han DJ
    Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients.
    Zecher D; Bach C; Preiss A; Staudner C; Utpatel K; Evert M; Jung B; Bergler T; Böger CA; Spriewald BM; Banas B
    Transplantation; 2018 Jun; 102(6):969-977. PubMed ID: 29470350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
    Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
    Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
    Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
    J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival.
    Redondo-Pachón D; Pascual J; Pérez-Sáez MJ; García C; Hernández JJ; Gimeno J; Mir M; Crespo M
    Transpl Immunol; 2016 Feb; 34():1-7. PubMed ID: 26603314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation.
    Lobashevsky A; Goggins W; Rosner K; Taber T
    Transpl Immunol; 2017 Aug; 43-44():42-48. PubMed ID: 28629951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
    Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
    Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.
    Nakamura T; Ushigome H; Watabe K; Imanishi Y; Masuda K; Matsuyama T; Harada S; Koshino K; Iida T; Nobori S; Yoshimura N
    Immunol Invest; 2017 Apr; 46(3):295-304. PubMed ID: 28151033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
    Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
    Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical utility and thresholds of virtual and Halifaster flow crossmatches in lung transplantation.
    Hiho SJ; Levvey B; Carroll R; Nicolson I; Mihaljcic M; Diviney MB; Snell GI; Sullivan LC; Westall GP
    HLA; 2022 Jun; 99(6):580-589. PubMed ID: 35340124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients.
    Lee KW; Park JB; Cho CW; Lee N; Yoo H; Kim K; Park H; Kang ES; Huh W; Kim S
    Ann Transplant; 2017 Mar; 22():166-176. PubMed ID: 28348361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.